Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review

BACKGROUND: Cystoid macular oedema (CMO) is an uncommon complication associated with hydroxychloroquine (HCQ) retinopathy threatening central vision. We report a patient with HCQ retinopathy and CMO, for which an intravitreal dexamethasone implant was used, which led to complete resolution of oedema...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Seong Joon, Joung, Jooyoung, Lee, Sang Hyup, Lee, Byung Ro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282365/
https://www.ncbi.nlm.nih.gov/pubmed/30522457
http://dx.doi.org/10.1186/s12886-018-0985-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282365/
https://www.ncbi.nlm.nih.gov/pubmed/30522457
http://dx.doi.org/10.1186/s12886-018-0985-x

Ejemplares similares